Related references
Note: Only part of the references are listed.Cerebrospinal Fluid Penetration of High-Dose Daptomycin in Suspected Staphylococcus aureus Meningitis
M. Shawn Riser et al.
ANNALS OF PHARMACOTHERAPY (2010)
Attenuation of Cerebrospinal Fluid Inflammation by the Nonbacteriolytic Antibiotic Daptomycin versus That by Ceftriaxone in Experimental Pneumococcal Meningitis
Denis Grandgirard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin
Jose M. Entenza et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy
Pamela A. Moise et al.
ANNALS OF PHARMACOTHERAPY (2009)
Combination of Daptomycin plus Ceftriaxone Is More Active than Vancomycin plus Ceftriaxone in Experimental Meningitis after Addition of Dexamethasone
U. Egermann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Safety of High-Dose Intravenous Daptomycin Treatment: Three-Year Cumulative Experience in a Clinical Program
D. A. Figueroa et al.
CLINICAL INFECTIOUS DISEASES (2009)
Telavancin: A Novel Lipoglycopeptide
Louis D. Saravolatz et al.
CLINICAL INFECTIOUS DISEASES (2009)
In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: Tigecycline Evaluation and Surveillance Trial 2004 to 2007
Mark W. Garrison et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Strategies and New Developments in the Management of Bacterial Meningitis
Justine Miranda et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)
Failure of linezolid therapy for post-neurosurgical meningitis due to Enterococcus faecium
Daniel P. Webster et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Daptomycin Therapy for Vancomycin-Resistant Enterococcal Bacteremia: A Retrospective Case Series of 30 Patients
Jason C. Gallagher et al.
PHARMACOTHERAPY (2009)
Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection
Pamela A. Moise et al.
ANNALS OF PHARMACOTHERAPY (2008)
Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations
Warren E. Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus
Nicole Cotroneo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Successful treatment of methicillin-resistant Staphylococcus aureus meningitis with daptomycin
Dong Heun Lee et al.
CLINICAL INFECTIOUS DISEASES (2008)
Activity of serum concentrations of daptomycin vs. vancomycin against vancomycin-susceptible and resistant Enterococcus faecium in the presence of albumin physiological concentrations: an in vitro pharmacodynamic simulation
L. Alou et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007
Alicia I. Hidron et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin
Juliet Elvy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis:: an in vitro and in vivo simulation using historical and current dosing strategies
Warren E. Rose et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall
A. Stucki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium
Jochen Abb
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection
Jamela Seedat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers
Mark Benvenuto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis
T-N Tsai et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis
P Gerber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin
G Pankey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy:: a case report
S Swoboda et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis
P Cottagnoud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model
KL LaPlante et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
D Cardo et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2004)
In vitro activity of daptomycin against vancomycin-resistant enterococci of various van types and comparison of susceptibility testing methods
JH Jorgensen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides
J Gavaldà et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Antimicrobial activity of tigecycline (GAR-936) against Enterococcus faecium and Staphylococcus aureus used alone and in combination
RC Mercier et al.
PHARMACOTHERAPY (2002)
In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model
GP Allen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis
PL Graham et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid
CJ Gill et al.
JOURNAL OF INFECTION (2002)
Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin- resistant enterococci
GM Eliopoulos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Pharmacokinetics and inflammatory fluid penetration of intravenous daptomycin in volunteers
R Wise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: Case report and review of the literature
MP Steinmetz et al.
CRITICAL CARE MEDICINE (2001)
Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid:: Case report and review of the literature
C Zeana et al.
CLINICAL INFECTIOUS DISEASES (2001)
Linezolid for the treatment of resistant gram-positive cocci
KT Bain et al.
ANNALS OF PHARMACOTHERAPY (2001)
In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae
R Patel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2000)
Share Paper
